What SquareMind does
SquareMind has built Swan, described as the first robot for full-body dermoscopy, which uses an articulated arm to scan and digitize a patient's entire skin surface. The system pairs dermoscopy imaging with AI-based change detection to help clinicians identify new or evolving skin lesions between exams. The company says the goal is to make comprehensive skin exams faster and more accessible; the device is currently offered via a waitlist ahead of wider availability.
SquareMind is a healthcare tool on Falcoscan. Robot arm that performs full-body dermoscopy scans with AI-based skin change detection. Falcoscan rates SquareMind with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. SquareMind is founded in 2019, currently at Series_a stage. Pricing: Paid.